June 2013
Volume 54, Issue 15
Free
ARVO Annual Meeting Abstract  |   June 2013
Retinal Oximetry Demonstrates Differences in Vessel Oxygen Saturation by Severity of Diabetic Retinopathy
Author Affiliations & Notes
  • Alexa Waters
    Ophthalmology, University of North Carolina, Chapel Hill, NC
  • Justin Miller
    Ophthalmology, University of North Carolina, Chapel Hill, NC
  • Jean-Claude Mwanza
    Ophthalmology, University of North Carolina, Chapel Hill, NC
  • Seema Garg
    Ophthalmology, University of North Carolina, Chapel Hill, NC
  • Footnotes
    Commercial Relationships Alexa Waters, None; Justin Miller, None; Jean-Claude Mwanza, None; Seema Garg, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science June 2013, Vol.54, 2445. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to Subscribers Only
      Sign In or Create an Account ×
    • Get Citation

      Alexa Waters, Justin Miller, Jean-Claude Mwanza, Seema Garg; Retinal Oximetry Demonstrates Differences in Vessel Oxygen Saturation by Severity of Diabetic Retinopathy. Invest. Ophthalmol. Vis. Sci. 2013;54(15):2445.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: To measure retinal vessel oxygen saturation (SO2) using retinal oximetry in healthy subjects and in diabetic patients with one of three clinical stages: no diabetic retinopathy (DR), mild non-proliferative DR (NPDR) and moderate NPDR. In order to evaluate SO2 in the context of diabetic status and retinal vascular perfusion, HbA1c, urine microalbumin and fluorescein angiography (FA) were obtained.

Methods: Retinal vessel SO2 was measured in 16 diabetics with no DR, 16 diabetics with early DR (5 with mild NPDR and 11 with moderate NPDR) and 27 age-matched healthy subjects using a retinal oximeter (Oxymap ehf., Reykjavik, Iceland). Arterial saturation (SaO2), venous saturation (SvO2) and arteriovenous (A-V) difference for each subject were calculated within a ring-shaped measurement area concentric to the optic disc. For diabetic patients, HbA1c, urine microalbumin and FA (% ischemia in ring) were also analyzed for correlation.

Results: Patients with moderate NPDR showed a significant increase in SvO2 compared to healthy subjects and diabetics with no DR (p=0.018, 0.047; respectively) and a nearly significant increase compared to diabetics with mild NPDR (p=0.057). Moderate NPDR patients also showed a significant decrease in A-V difference compared to healthy subjects, diabetics with no DR and diabetics with mild NPDR (p=0.003, 0.033, 0.016; respectively). SaO2 was approximately equal across all groups. Age showed significant negative correlation with SaO2 (r =-0.449, p=0.0004) and SvO2 (r =-0.466, p=0.0002) and nearly significant positive correlation with A-V difference (r=-0.243, p=0.064). In diabetic patients, no correlation between SO2 or A-V difference was found with HbA1c, urine microalbumin or FA (% ischemia in ring). In multivariate regression analysis, age and history of hypertension were significant determinants of A-V difference (β=1.507, p=0.012; β=-1.208, p=0.018, respectively).

Conclusions: In this preliminary study, increased SvO2 and decreased A-V difference were found in patients with moderate NPDR compared to earlier stages of DR and healthy subjects. This may signify decreased delivery of oxygen to retinal tissues in patients with early DR and/or decreased tissue extraction of oxygen. Future studies of diabetic patients across all DR stages are ongoing to correlate retinal oxygenation with FA and systemic markers of diabetic severity.

Keywords: 499 diabetic retinopathy • 552 imaging methods (CT, FA, ICG, MRI, OCT, RTA, SLO, ultrasound) • 688 retina  
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×